399 related articles for article (PubMed ID: 11752513)
1. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.
Ravirajan CT; Rowse L; MacGowan JR; Isenberg DA
Rheumatology (Oxford); 2001 Dec; 40(12):1405-12. PubMed ID: 11752513
[TBL] [Abstract][Full Text] [Related]
2. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
[TBL] [Abstract][Full Text] [Related]
3. Serum IgG2 antibody multicomposition in systemic lupus erythematosus and lupus nephritis (Part 1): cross-sectional analysis.
Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Mosca M; Tincani A; Candiano G; Prunotto M; Volpi S; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
Rheumatology (Oxford); 2021 Jul; 60(7):3176-3188. PubMed ID: 33374003
[TBL] [Abstract][Full Text] [Related]
4. Anti-heparan sulphate reactivity in sera from patients with systemic lupus erythematosus with renal or non-renal manifestations.
Termaat RM; Brinkman K; Nossent JC; Swaak AJ; Smeenk RJ; Berden JH
Clin Exp Immunol; 1990 Nov; 82(2):268-74. PubMed ID: 2242607
[TBL] [Abstract][Full Text] [Related]
5. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
[TBL] [Abstract][Full Text] [Related]
6. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
7. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin.
Wang H; Li T; Chen S; Gu Y; Ye S
Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802
[TBL] [Abstract][Full Text] [Related]
9. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
10. Autoimmunity against nucleosomes and lupus nephritis.
Van Bruggen MC; Kramers C; Berden JH
Ann Med Interne (Paris); 1996; 147(7):485-9. PubMed ID: 9092359
[TBL] [Abstract][Full Text] [Related]
11. Serum IgG2 antibody multi-composition in systemic lupus erythematosus and in lupus nephritis (Part 2): prospective study.
Bruschi M; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Bagnasco M; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Cipriani L; Trezzi B; Emmi G; Cavazzana I; Binda V; d'Alessandro M; Fenaroli P; Pisani I; Garibotto G; Montecucco C; Santoro D; Scolari F; Volpi S; Mosca M; Tincani A; Candiano G; Prunotto M; Verrina E; Angeletti A; Ravelli A; Ghiggeri GM
Rheumatology (Oxford); 2021 Jul; 60(7):3388-3397. PubMed ID: 33351137
[TBL] [Abstract][Full Text] [Related]
12. Circulating plasma levels of nucleosomes in patients with systemic lupus erythematosus: correlation with serum antinucleosome antibody titers and absence of clear association with disease activity.
Amoura Z; Piette JC; Chabre H; Cacoub P; Papo T; Wechsler B; Bach JF; Koutouzov S
Arthritis Rheum; 1997 Dec; 40(12):2217-25. PubMed ID: 9416860
[TBL] [Abstract][Full Text] [Related]
13. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
[TBL] [Abstract][Full Text] [Related]
14. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
Williams RC; Malone CC; Meyers C; Decker P; Muller S
J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
[TBL] [Abstract][Full Text] [Related]
15. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
[TBL] [Abstract][Full Text] [Related]
17. Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.
Okamura M; Kanayama Y; Amastu K; Negoro N; Kohda S; Takeda T; Inoue T
Ann Rheum Dis; 1993 Jan; 52(1):14-20. PubMed ID: 8427508
[TBL] [Abstract][Full Text] [Related]
18. IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.
Bijl M; Dijstelbloem HM; Oost WW; Bootsma H; Derksen RH; Aten J; Limburg PC; Kallenberg CG
Rheumatology (Oxford); 2002 Jan; 41(1):62-7. PubMed ID: 11792881
[TBL] [Abstract][Full Text] [Related]
19. Anti-heparan sulfate antibody and functional loss of glomerular heparan sulfate proteoglycans in lupus nephritis.
Kim HJ; Hong YH; Kim YJ; Kim HS; Park JW; Do JY; Kim KJ; Bae SW; Kim CW; Lee CK
Lupus; 2017 Jul; 26(8):815-824. PubMed ID: 28420046
[TBL] [Abstract][Full Text] [Related]
20. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]